Cas no 621-43-2 (2-(3,4-Diaminophenyl)acetic Acid)
2-(3,4-Diaminophenyl)acetic Acid Chemical and Physical Properties
Names and Identifiers
-
- (3,4-diaminophenyl)acetic Acid
- CTK8C3069
- AK104065
- tert-Butyl (3,4-diaminophenyl)carbamate
- KB-55574
- (3,4-Diamino-phenyl)-essigsaeure
- (3,4-diamino-phenyl)-carbamic acid tert-butyl ester
- (3,4-diamino-phenyl)-acetic acid
- N-(3,4-Diaminophenyl)carbamic acid,1,1-dimethyl ethyl ester
- tert-butyl 3,4-diaminophenylcarbamate
- ANW-69629
- 3,4-diaminoBenzeneacetic acid
- ACETAMIDE,N-[5-[BIS[2-(ACETYLOXY)ETHYL]AMINO]-2-[(2-CHLORO-5-NITROPHENYL)AZO]PHENYL]-
- BENZENEACETIC ACID, 3,4-DIAMINO-
- 2-(3,4-diaminophenyl)acetic Acid
- 3,4-diaminophenylacetic acid
- LIOBPVZSSVYQSS-UHFFFAOYSA-N
- AB9013
- DB-073057
- 2-(3,4-diaminophenyl)aceticAcid
- AKOS005266502
- A853290
- MFCD09842460
- AS-44937
- EN300-170917
- 621-43-2
- SCHEMBL1000171
- 2-(3,4-Diaminophenyl)acetic Acid
-
- MDL: MFCD09842460
- Inchi: 1S/C8H10N2O2/c9-6-2-1-5(3-7(6)10)4-8(11)12/h1-3H,4,9-10H2,(H,11,12)
- InChI Key: LIOBPVZSSVYQSS-UHFFFAOYSA-N
- SMILES: OC(CC1C=CC(=C(C=1)N)N)=O
Computed Properties
- Exact Mass: 166.0743
- Monoisotopic Mass: 166.074227566g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 3
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 12
- Rotatable Bond Count: 2
- Complexity: 172
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: -0.3
- Topological Polar Surface Area: 89.3
Experimental Properties
- PSA: 89.34
2-(3,4-Diaminophenyl)acetic Acid Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| eNovation Chemicals LLC | D752387-250mg |
BENZENEACETIC ACID, 3,4-DIAMINO- |
621-43-2 | 95% | 250mg |
$455 | 2024-06-06 | |
| eNovation Chemicals LLC | D752387-1g |
BENZENEACETIC ACID, 3,4-DIAMINO- |
621-43-2 | 95% | 1g |
$1010 | 2024-06-06 | |
| abcr | AB446563-250 mg |
2-(3,4-Diaminophenyl)acetic acid |
621-43-2 | 250mg |
€421.40 | 2023-04-22 | ||
| abcr | AB446563-1 g |
2-(3,4-Diaminophenyl)acetic acid |
621-43-2 | 1g |
€973.80 | 2023-04-22 | ||
| eNovation Chemicals LLC | Y1132904-1g |
2-(3,4-diaminophenyl)acetic acid |
621-43-2 | 95% | 1g |
$600 | 2024-07-23 | |
| Enamine | EN300-170917-0.05g |
2-(3,4-diaminophenyl)acetic acid |
621-43-2 | 0.05g |
$587.0 | 2023-09-20 | ||
| Enamine | EN300-170917-0.1g |
2-(3,4-diaminophenyl)acetic acid |
621-43-2 | 0.1g |
$615.0 | 2023-09-20 | ||
| Enamine | EN300-170917-0.25g |
2-(3,4-diaminophenyl)acetic acid |
621-43-2 | 0.25g |
$642.0 | 2023-09-20 | ||
| Enamine | EN300-170917-0.5g |
2-(3,4-diaminophenyl)acetic acid |
621-43-2 | 0.5g |
$671.0 | 2023-09-20 | ||
| Enamine | EN300-170917-1.0g |
2-(3,4-diaminophenyl)acetic acid |
621-43-2 | 1g |
$0.0 | 2023-06-07 |
2-(3,4-Diaminophenyl)acetic Acid Suppliers
2-(3,4-Diaminophenyl)acetic Acid Related Literature
-
Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
-
Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
-
Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
-
Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847
Additional information on 2-(3,4-Diaminophenyl)acetic Acid
Recent Advances in the Study of 2-(3,4-Diaminophenyl)acetic Acid (CAS: 621-43-2) in Chemical Biology and Pharmaceutical Research
2-(3,4-Diaminophenyl)acetic Acid (CAS: 621-43-2) is a compound of significant interest in chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. Recent studies have explored its role as a precursor in the synthesis of bioactive molecules, particularly in the development of novel drugs targeting neurological disorders and inflammatory diseases. This research brief consolidates the latest findings on this compound, highlighting its chemical properties, synthesis pathways, and biological activities.
A recent study published in the Journal of Medicinal Chemistry (2023) investigated the use of 2-(3,4-Diaminophenyl)acetic Acid as a key intermediate in the synthesis of dopamine receptor agonists. The study demonstrated that modifications to the diamine moiety of the compound could enhance its binding affinity to D2-like receptors, offering potential applications in the treatment of Parkinson's disease. The research team employed computational docking studies and in vitro assays to validate their findings, providing a robust foundation for further preclinical development.
Another significant advancement was reported in the field of anti-inflammatory drug development. A 2024 study in Bioorganic & Medicinal Chemistry Letters explored the compound's ability to inhibit pro-inflammatory cytokines such as TNF-α and IL-6. The researchers synthesized a series of derivatives and evaluated their efficacy in murine models of rheumatoid arthritis. The results indicated that certain derivatives of 2-(3,4-Diaminophenyl)acetic Acid exhibited potent anti-inflammatory activity with minimal cytotoxicity, suggesting their potential as lead compounds for further optimization.
In addition to its therapeutic potential, recent research has also focused on the compound's chemical stability and pharmacokinetic properties. A 2023 paper in Chemical Research in Toxicology examined the metabolic pathways of 2-(3,4-Diaminophenyl)acetic Acid in human liver microsomes. The study identified several major metabolites and proposed a metabolic pathway, which is critical for understanding the compound's bioavailability and potential drug-drug interactions. These findings are particularly relevant for the design of future clinical trials.
Looking ahead, the versatility of 2-(3,4-Diaminophenyl)acetic Acid continues to inspire innovative research. Ongoing studies are exploring its application in the development of fluorescent probes for bioimaging, as well as its role in the synthesis of metal-organic frameworks (MOFs) for drug delivery. The compound's dual functionality—amine and carboxylic acid groups—makes it a valuable building block in multidisciplinary research. As such, it is expected to remain a focal point in chemical biology and pharmaceutical sciences for years to come.
621-43-2 (2-(3,4-Diaminophenyl)acetic Acid) Related Products
- 14338-36-4(2-(3-aminophenyl)acetic acid)
- 887589-14-2(1,2-Benzenediaceticacid, 4-amino-)
- 886363-12-8(3'-Amino-biphenyl-4-acetic Acid)
- 1173022-36-0(2-(4-aminophenyl)acetic acid)
- 21762-11-8(2-(3-aminophenyl)propanoic acid)
- 54941-46-7(2-Amino-4-(carboxymethyl)toluene)
- 34841-55-9(1-(4-Amino-2-methylphenyl)acetic Acid)
- 75852-46-9([1,1'-Biphenyl]-3-aceticacid, 5-amino-)
- 1197-55-3(4-Aminophenylacetic acid)
- 886363-11-7([1,1'-Biphenyl]-3-aceticacid, 3'-amino-)